Exactmer owns the Nanostar Sieving technology platform. This employs iterative, liquid-phase chemistry coupled to membrane purification, to create polymers of outstanding purity. Exactmer is currently advancing the production of oligonucleotides at scale, bringing these advanced therapeutics to all patients in need. Nanostar Sieving can also produce unimolecular polyethylene glycols (PEGs), including a disruptive new suite of multi-functional 'PEGabets', with handles for conjugation along the polymer backbone; ideal linkers molecules for Antibody Drug Conjugates.
| Website | http://www.exactmer.com |
| Employees | 22 (16 on RocketReach) |
| Founded | 2017 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Oligonucleotide Synthesis, Polymer Chemistry, Precision Polymers, Chemical Synthesis, Separation Technology, Biotechnology, Biomanufacturing, Synthetic Biology, Pharmaceutical Manufacturing, Nanotechnology, Materials Science, Advanced Materials, Drug Development |
| Competitors | HP, 3D Systems Corporation, Stratasys, Formlabs, Markforged, Prusa Research, UltiMaker, EOS, Additive Industries, ROBO 3D +36 more (view full list) |
Looking for a particular Exactmer employee's phone or email?
Cristina Bertulli is the Vice President of Business of Exactmer.
16 people are employed at Exactmer.